RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 64 filers reported holding RAIN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,939 | -88.0% | 2,250 | -83.3% | 0.00% | -100.0% |
| Q2 2023 | $16,154 | -85.2% | 13,462 | +8.0% | 0.00% | -75.0% |
| Q1 2023 | $108,918 | +9.3% | 12,462 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $99,696 | +63.4% | 12,462 | 0.0% | 0.00% | +33.3% |
| Q3 2022 | $61,000 | -11.6% | 12,462 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $69,000 | +11.3% | 12,462 | +5.5% | 0.00% | +50.0% |
| Q1 2022 | $62,000 | -58.1% | 11,812 | +2.6% | 0.00% | -60.0% |
| Q4 2021 | $148,000 | +3600.0% | 11,512 | +3737.3% | 0.01% | – |
| Q3 2021 | $4,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,560,652 | $7,616,000 | 1.78% |
| Cormorant Asset Management, LP | 2,326,660 | $11,354,000 | 0.79% |
| BVF INC/IL | 3,526,729 | $17,210,000 | 0.71% |
| Perceptive Advisors | 2,483,619 | $12,120,000 | 0.35% |
| Boxer Capital, LLC | 1,175,000 | $5,734,000 | 0.32% |
| UBS OCONNOR LLC | 326,451 | $1,593,000,000 | 0.03% |
| Ergoteles LLC | 65,096 | $318,000 | 0.01% |
| Lumina Fund Management LLC | 6,000 | $29,000 | 0.01% |
| Laurion Capital Management LP | 313,200 | $1,528,000 | 0.01% |
| Woodline Partners LP | 119,700 | $584,000 | 0.01% |